Ponatinib Hydrochloride Patent Expiration

Ponatinib Hydrochloride is used for treating various types of leukemia, including acute lymphoblastic leukemia, chronic myeloid leukemia, and Philadelphia chromosome-positive acute lymphoblastic leukemia. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Iclusig on Dec 14, 2012. 2 different companies have introduced drugs containing Ponatinib Hydrochloride.


Ponatinib Hydrochloride Patents

Given below is the list of patents protecting Ponatinib Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Iclusig US11192895 Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Dec 12, 2033 Takeda Pharms Usa
Iclusig US11192897 Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Dec 12, 2033 Takeda Pharms Usa
Iclusig US11384086 Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1- yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Dec 12, 2033 Takeda Pharms Usa
Iclusig US9493470 Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Dec 12, 2033 Takeda Pharms Usa
Iclusig US8114874 Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors Jan 24, 2027 Takeda Pharms Usa
Iclusig US9029533 Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors Dec 22, 2026 Takeda Pharms Usa



Ponatinib Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ponatinib Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Ponatinib Hydrochloride.

Given below is the list of companies who have filed for Ponatinib Hydrochloride generic, along with the locations of their manufacturing plants worldwide.